News

For example ... Laura Hyland validated a new DNA-based blood test designed to detect minimal residual disease (MRD) in patients with B-cell cancers. This assay uses a highly sensitive method ...
Rui Tostoes, Chief Technology Officer at ImmuneBridge, shares how his team is redefining preclinical development and ...
Researchers developed a wearable pad that detects inflammation and cancer biomarkers in menstrual blood using smartphone ...
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced its ...
This fundamental study combines in vitro reconstitution experiments and molecular dynamics simulations to elucidate how membrane lipids are transported from the outer to the inner membrane of ...
REVEAL GENOMICS, S.L., a biotechnology company advancing precision oncology through biomarker innovation, today announced the ...
The Brazilian Reproducibility Initiative team could replicate less than half of regional research findings. How can ...
Transforming Preclinical Screening with Speed, Precision, and Scalability. Explore How This Model Organism is Shaping the Next Era of Pharmaceutical Innovation. Executive Summary & Key Findings Market ...
Unraveling the Complexities, Risks, and Latest Breakthroughs in Diagnosis and Treatment Introduction to Coxsackievirus: Classification and Virology Epidemiology and Global Distribution Patterns ...
In a leap forward for genetic and biomedical research, two scientists at the University of Missouri have developed a powerful ...
This valuable study investigates how stochastic and deterministic factors are integrated during cellular decision-making, particularly in situations where cells differentiate into distinct fates ...